Atlas FDA

ENDEAVOR SPRINT ZOTAROLIMUS-ELUTING CORONARY STENT SYSTEM

FDA premarket approval P060033/S069 · decided 2012-07-31

Approval details

PMA number
P060033
Supplement
S069
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Labeling Change - PAS
Trade name
ENDEAVOR SPRINT ZOTAROLIMUS-ELUTING CORONARY STENT SYSTEM
Generic name
Coronary drug-eluting stent
Applicant
Medtronic, Inc.
Date received
2012-03-19
Decision date
2012-07-31
Days to decision
134 days
Decision code
APPR
Product code
NIQ
Advisory committee
Cardiovascular
Expedited review
No
Location
Santa Rosa, CA
Statement
APPROVAL FOR CHANGES TO THE INSTRUCTIONS FOR USE (WITH THE LATEST AVAILABLE FOLLOW-UP CLINICAL DATA FROM THE ENDEAVOR CLINICAL TRIAL PROGRAMS).

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
VitalFlow Set with Balance™ Biosurface (K261335)Medtronic, Inc.2026-07-31
Concerto Versa™ Detachable Coil (K261866)Medtronic, Inc.2026-06-24
Elongated One-Piece Arterial (EOPA) 3D™ Arterial Cannulae (K260195)Medtronic, Inc.2026-04-23
Retrograde Coronary Sinus Perfusion Cannulae (K253203)Medtronic, Inc.2026-02-19
Clearview Intracoronary Shunts (K253998)Medtronic, Inc.2026-01-20
Bio-Medicus Life Support Catheter and Introducer (K251831)Medtronic, Inc.2026-01-15
Concerto Versa™ Detachable Coil (K253511)Medtronic, Inc.2026-01-14
C320LBB Delivery System (C320LBBS45), C320LBB Delivery System (C320LBBS48), C320LBB Delivery System (C320LBBL45), C320LBB Delivery System (C320LBBL48) (K253409)Medtronic, Inc.2025-12-19